Human Papillomavirus News and Research RSS Feed - Human Papillomavirus News and Research

Vaccinations could have significant economic value

Vaccinations could have significant economic value

Vaccinations, long recognized as an excellent investment that saves lives and prevents illness, could have significant economic value that far exceeds their original cost, a new study from researchers at the Johns Hopkins Bloomberg School of Public Health has found. [More]
Newly drafted consensus statement promotes widespread use of HPV vaccines to prevent cancer

Newly drafted consensus statement promotes widespread use of HPV vaccines to prevent cancer

Leaders of several cancer centers designated by the National Cancer Institute have united to support human papillomavirus vaccination. Among them is Cheryl Willman, MD, Director and CEO of the University of New Mexico Comprehensive Cancer Center. [More]
Beta- and gamma-HPVs associated with development of head and neck cancers, finds Einstein study

Beta- and gamma-HPVs associated with development of head and neck cancers, finds Einstein study

Researchers at Albert Einstein College of Medicine have found that when human papillomavirus (HPV)-16 is detected in peoples' mouths, they are 22 times more likely than those without HPV-16 to develop a type of head and neck cancer. [More]
Not all pediatricians recommend HPV vaccine for eleven- and twelve-year olds

Not all pediatricians recommend HPV vaccine for eleven- and twelve-year olds

In a society that has become increasingly suspicious of vaccines, it's not only parents who stand in the way of some children getting vaccinated for human papillomavirus (HPV). A new study published in Pediatrics shows not all pediatricians are recommending or even discussing the HPV virus for eleven- and twelve-year olds. [More]
UTHealth receives nearly $5.7 million from CPRIT for cancer research

UTHealth receives nearly $5.7 million from CPRIT for cancer research

The Cancer Prevention & Research Institute of Texas has awarded nearly $5.7 million in grants to The University of Texas Health Science Center at Houston School of Public Health. The grants will fund projects that train innovative cancer researchers, increase breast and cervical cancer screening among Hispanics and raise awareness about the human papillomavirus (HPV) vaccine. [More]
Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

Janssen Pharmaceuticals, Inc. announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen's own AdVac® technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of Human Papillomavirus (HPV) chronic infections which can lead to cancer. [More]
Novel strategies on the way for difficult-to-treat head and neck cancer

Novel strategies on the way for difficult-to-treat head and neck cancer

Novel strategies are on the way for difficult-to-treat and advanced head and neck cancer, the most heterogeneous group of malignancies which are generally associated with poor survival, and encouraging results have been presented at the first ESMO Asia 2015 Congress in Singapore. [More]
Improved Survival In HPV-Positive Oropharyngeal Cancer Patients Confirmed

Improved Survival In HPV-Positive Oropharyngeal Cancer Patients Confirmed

A large population-based study has confirmed the association between the presence of human papillomavirus DNA in oropharyngeal squamous cell cancer and improved patient survival. [More]
New cancer control interventions may decrease cancer burden in low- and middle-income countries

New cancer control interventions may decrease cancer burden in low- and middle-income countries

In low-income and middle-income countries (LMICs), where 5.5 million of the world’s 8 million cancer deaths occur each year, most people with cancer have little or no access to treatment and many die in severe pain for lack of inexpensive opioid pain medicine. [More]
European regulator concludes that evidence does not support a causal relationship between human papillomavirus vaccines and CRPS or POTS

European regulator concludes that evidence does not support a causal relationship between human papillomavirus vaccines and CRPS or POTS

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a detailed scientific review of the evidence surrounding reports of two syndromes, complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS) in young women given human papillomavirus (HPV) vaccines. [More]
Research sheds new light on the fight against tonsil cancer

Research sheds new light on the fight against tonsil cancer

Researchers at Simon Fraser University and the BC Cancer Agency have developed a groundbreaking method to identify and separate stem cells that reside in the tonsils. Their research, which sheds new light on the fight against oral cancer, is published today in the journal Stem Cell Reports. [More]
UofL evaluates safety of new therapeutic vaccine in women with HPV 16, 18 infections

UofL evaluates safety of new therapeutic vaccine in women with HPV 16, 18 infections

Cervical cancer is the fourth most frequently occurring cancer in women. Human papillomavirus (HPV) is present in 99 percent of cervical cancers and is considered to be their cause. While most HPV infections will clear naturally within a few years, there has been no treatment available to hasten or improve the chance of natural eradication. [More]
First patient of U.S. phase 1 trial treated with Genticel’s GTL001 candidate for HPV 16/18 infections

First patient of U.S. phase 1 trial treated with Genticel’s GTL001 candidate for HPV 16/18 infections

Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus, today announces that the first patient of the U.S. phase 1 clinical trial has been vaccinated with GTL001, the company’s first-in-class therapeutic vaccine candidate against HPV 16/18 infections. [More]
Outreach program increases completion of HPV vaccination series by teens in safety-net settings

Outreach program increases completion of HPV vaccination series by teens in safety-net settings

A joint study by UT Southwestern Medical Center and Parkland Health & Hospital System investigators found that a multicomponent outreach program increased completion of the three-dose human papillomavirus (HPV) vaccination series that reduces the risk of cervical cancer caused by the virus. [More]
Prevention of cervical cancer in Latin America

Prevention of cervical cancer in Latin America

The latest Special Issue from ecancermedicalscience collects four new research articles on the topic of cervical cancer prevention in Latin America. [More]
UT Southwestern announces launch of new health initiative

UT Southwestern announces launch of new health initiative

UT Southwestern Medical Center today announced the launch of "Call Out Cancer," a new health initiative designed to promote awareness, early detection, and prevention of all types of cancer. [More]
Radical surgery associated with overall survival benefits among patients with advanced throat cancer

Radical surgery associated with overall survival benefits among patients with advanced throat cancer

Patients with cancers of the mid- and lower throat may have higher survival rates if their initial treatment includes surgery, according to new research presented to the 2015 European Cancer Congress today (Saturday). [More]
Cattle virus found in human cancer cells

Cattle virus found in human cancer cells

Evidence of exposure to bovine leukaemia virus (BLV) has been found in human breast cancer samples. This is the first suggestion of a possible link between infection with a leukaemia virus prevalent in cows and breast cancer in humans. [More]
Researchers establish link between bovine leukemia virus and human breast cancer

Researchers establish link between bovine leukemia virus and human breast cancer

A new study by University of California, Berkeley, researchers establishes for the first time a link between infection with the bovine leukemia virus and human breast cancer. [More]
Meridian Health Plan has second highest rate of HPV vaccinations in U.S. for female adolescents

Meridian Health Plan has second highest rate of HPV vaccinations in U.S. for female adolescents

Meridian Health Plan of Illinois has the second highest rate of human papillomavirus (HPV) vaccinations for female adolescents among all health plans in the country reporting HEDIS data to the National Committee for Quality Assurance. [More]
Advertisement
Advertisement